Related Experiment Video
Updated: Apr 22, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
How I treat splanchnic vein thrombosis
Walter Ageno1, Francesco Dentali1, Alessandro Squizzato1
1Research Center on Thromboembolic Diseases and Antithrombotic Therapies, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.
Antithrombotic treatment for splanchnic vein thrombosis (SVT) is complex due to bleeding risks. This review offers practical guidance for anticoagulant use in SVT patients, balancing benefits and risks.
Area of Science:
- Vascular Medicine
- Hematology
- Gastroenterology
Background:
- Splanchnic vein thrombosis (SVT) presents unique challenges in antithrombotic treatment.
- Patients with SVT face risks of liver insufficiency, portal hypertension, bowel infarction, and recurrence.
- Active bleeding and risk factors like esophageal varices complicate anticoagulant therapy initiation.
More Related Videos
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care